| The Institute of Molecular and Cell Biology (IMCB) was launched on 23 January 1985, with the official opening ceremony held on 2 October 1987 at the National University of Singapore (NUS), to develop and support the biomedical R&D capabilities in Singapore. It subsequently became an autonomous research institute (RI) of the Agency for Science, Technology and Research (A*STAR), moving to Biopolis in 2004.|
The vision of the Institute of Molecular and Cell Biology (IMCB) is to be a premier cell and molecular biology institute which addresses the mechanistic basis of human diseases. Its mission is to conduct cutting-edge discovery research in disease pathways; to groom early career researchers to be future leaders in research and to collaborate with medical and industry communities for research impact. IMCB continues to play an important role in training and recruiting scientific talents and has contributed to the development of other research entities in Singapore’s R&D ecosystem. Its success in fostering a biomedical research culture in Singapore has catalysed Singapore’s transformation into an international hub for biomedical research, development and innovation.
Our mission is to:
IMCB’s research comprises of 4 pillars of scientific programmes:
- conduct cutting-edge discovery research in disease pathways
- groom early career researchers to be future leaders in their fields
- collaborate with medical & industry communities for research impact
IMCB’s technologies and platforms focus on Mouse Models of Diseases, Molecular Histopathology, Cellular Microscopy and Proteomics & Metabolomics. In addition, IMCB also hosts a semi-autonomous program; the Molecular Engineering Laboratory. Through these programmes, IMCB aims to be a scientific leader with peaks of global excellence.
- Neurometabolism in Health & Diseases
- Cancer Signalling & Therapies
- Cell Biology & Therapies
- Innovative Technologies